Navigation Links
Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs

Despite Black Box Warnings (BBW) issued for high-risk medication by the FDA, doctors have been found to prescribe such medicines to ambulatory care patients. The percentage of patients found to receive // such drugs was nearly 42% according to a survey conducted by Harvard Medical School and Harvard Pilgrim Health Care.

The response of the doctors to comply with recommendations of the BBWs was highly variable, with noncompliance rates soaring from 0.3 % to 49.6%. In view of the fact that more than 1.4 million prescriptions are written per year in ambulatory settings, appropriate methods are needed for ensuring patient safety and maximizing benefits of drug therapy.

BBWs are warnings printed in a black frame in the package insert of a drug. It contains details regarding the drug safety, precautions and adverse effects. It is intended to alert prescribers to the serious risks that may be associated with certain drugs.

The present study assessed 217,000 participants who were prescribed the medication. The duration of prescription, other medications and possible drug interactions, and pregnancy status were taken into consideration during the evaluation process.

Noncompliance was noted in each of these categories, with a majority of the prescriptions were given away without a lab test that was mandatory. Recommendations for pregnancy tests were most frequently not observed. There was no sustained lab monitoring while taking the medication. Furthermore, nearly 9% of medications were given with a drug combination regarded unsafe (methotrexate with non-steroidal anti-inflammatory drugs). An excellent compliance was noted with respect to taking the medication during pregnancy as it was avoided in most of the cases.

An effective strategy to communicate the risks associated with such medicines is the need of the hour. It has to be targeted at both patients and physicians. For example, in the opinion of the authors, patient speci
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
(Date:9/2/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... that protects people from crime and other hostile situations. , "The Security Services ... Creative Director of World Patent Marketing. "The industry is growing at a healthy ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most ...
(Date:9/2/2015)... ... September 02, 2015 , ... Please join the world renowned ... which was established by the Foundation in 2007 with the help of Massachusetts ... more research remains our top priority,” commented Christine Buckley, Executive Director of the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Mobile working is increasingly more important, ... seems that everywhere new mobile apps are being launched, and mobile device usage as ... regular part of their work and personal lives. What's more people are expecting mobile ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
Breaking Medicine News(10 mins):Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... Inc. (NYSE: FRX ) today announced that ... the Company,s supplemental New Drug Application (sNDA) for Lexapro ... Major Depressive Disorder (MDD) in adolescents, 12 - 17 ... to be approved for the treatment of MDD in ...
... Finding could lead to new treatments for cognitive ... News) -- The human brain functions on "the ... order and randomness, according to U.K.-based researchers who ... cognitive performance and psychiatric disorders. , The ...
... 20 CANTEL MEDICAL CORP. (NYSE: ... of the Company, to President and Chief Executive Officer. ... of Directors. Since joining Cantel in September 2004, Mr. Krakauer ... 2008 as President. The Board concurrently appointed Seth R. Segel, ...
... the Migraine Research Foundation (MRF) announced a new initiative ... migraine called FOR OUR CHILDREN. The new program ... understanding of migraine and its causes and treatments in ... , Migraine is very common in children - ...
... SEGUNDO, Calif., March 20 A former astronaut and ... a director of business development for Wyle,s Integrated Science ... Parazynski joins Wyle to assist in the company,s continued ... health and performance services to the Federal Government. He ...
... obscure clinical manifestation of severe vomiting sickness due to ... his colleagues at the Creighton University of Omaha, NE, ... of Gastroenterology . , Recent research into the neurobiology ... receptor types including two specific types that mediate neuropsychiatric ...
Cached Medicine News:Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 2Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 3Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 4Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 5Health News:Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents 6Health News:Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments 2Health News:New initiative to support pediatric migraine research is announced 2Health News:Veteran Astronaut Joins Wyle Business Development Staff in Houston 2
(Date:9/2/2015)... 2, 2015 /PRNewswire/ -- VolitionRx Limited (NYSE MKT: VNRX), a ... a broad range of cancer types and other conditions, today ... is scheduled to present at the 17 th Annual ... 2015 in New York, NY . In ... will be presenting at the CNAPS (Circulating Nucleic Acids in ...
(Date:9/2/2015)... 2, 2015 On Tuesday, September ... of physicians who prescribe biologics – Alliance ... Endocrinologists, American College of Rheumatology, Biologics Prescribers ... North American Society for Pediatric Gastroenterology, Hepatology ... Centers for Medicare and Medicaid Services (CMS) ...
(Date:9/2/2015)... SARASOTA, Fla. , Sept. 2, 2015   ... announced a new capital infusion of $17 million by ... of Cerner Corporation, and Bedford Funding. Series D funding ... Voalte has raised to nearly $60 million in three ... to sustain a triple-digit growth trajectory for Voalte. The ...
Breaking Medicine Technology:VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 2VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 3VolitionRx to Present at Rodman & Renshaw 17th Annual Global Investment Conference in New York and CNAPS IX Conference in Berlin on September 9 and 11, 2015 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 2Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 3Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 5Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 6Voalte Raises $17 Million in Series D Financing 2Voalte Raises $17 Million in Series D Financing 3Voalte Raises $17 Million in Series D Financing 4
... Synapse Biomedical Inc ... Food and Drug Administration (FDA) designation of the ... Use Device (HUD) for amyotrophic lateral sclerosis ( ALS ... chronic hypoventilation and has now submitted for Humanitarian Device ...
... Varian Medical Systems (NYSE: VAR ) announced ... fiscal year 2010 following the close of regular trading on ... by a teleconference available to all interested parties at 2:00 ... conference call webcast will be available on the company website ...
Cached Medicine Technology:Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 2Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 3Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 4Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call 2
... the first commercially available real-time detection ... use. , ,The kit can detect ... genotypes of HPV providing the sensitivity ... simplifying the process by using a ...
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
Medicine Products: